SCD Risk Stratification: Which Patient Benefits from the Wearable Cardioverter Defibrillator?

1 September 2020 (18:35 - 18:45)

Organised by:

Video

Sign in to view the resources

About the speaker

Doctor Mauro Biffi

S. Orsola-Malpighi Policlinic, Bologna (Italy)

5 More presentations in this session

Presentation thumbnail

Introduction.

Presentation thumbnail

The Power of Per-Protocol Analyses: What Have We Learned from the VEST-Trial?

Professor S. Boveda (Toulouse, FR)

Presentation thumbnail

Predictors of Sudden Cardiac Death: What Role Does the Heart Rate Play?

Professor J. Sperzel (Bad Nauheim, DE)

Presentation thumbnail

Heart Failure Patient Management: Improved Outcomes for WCD Patients?

Professor D. Bondermann (Vienna, AT)

Presentation thumbnail

Discussion and Summary.

Professor C. Leclercq (Rennes, FR)

Access the full session

Session thumbnail

The Wearable Cardioverter Defibrillator (WCD): Clinical Update and Future Directions for the Management of Patients with Ventricular Arrhythmias

The Event

ESC Congress 2020

1 September 2020 18:35 CET

You may be interested in

Congress Session

Evolution in pacing and risk management strategies in sudden cardiac death

31 March 2025

Congress Presentation

Wearable Cardioverter Defibrillator (WCD) in Italy: results from the nationwide multicenter registry WEAR-ITA

23 April 2021

Congress Presentation

A spontaneous coronary artery dissection and a wearable cardioverter defibrillator, unusual couple?

18 March 2022

Congress Session

Oral anticoagulation in subclinical atrial fibrillation

31 March 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources